G. Helvacı And A. Bilgin, "New Horizons In Duchenne Muscle Dystrophy: Nuclear Factor Kappa Pathway And Therapeutic Effects Of Vamorolone," 2nd International Medicine And Pharmacy Congress , İstanbul, Turkey, pp.89-95, 2024
Helvacı, G. And Bilgin, A. 2024. New Horizons In Duchenne Muscle Dystrophy: Nuclear Factor Kappa Pathway And Therapeutic Effects Of Vamorolone. 2nd International Medicine And Pharmacy Congress , (İstanbul, Turkey), 89-95.
Helvacı, G., & Bilgin, A., (2024). New Horizons In Duchenne Muscle Dystrophy: Nuclear Factor Kappa Pathway And Therapeutic Effects Of Vamorolone . 2nd International Medicine And Pharmacy Congress (pp.89-95). İstanbul, Turkey
Helvacı, GÜLSÜM, And Aylin Bilgin. "New Horizons In Duchenne Muscle Dystrophy: Nuclear Factor Kappa Pathway And Therapeutic Effects Of Vamorolone," 2nd International Medicine And Pharmacy Congress, İstanbul, Turkey, 2024
Helvacı, GÜLSÜM And Bilgin, Aylin. "New Horizons In Duchenne Muscle Dystrophy: Nuclear Factor Kappa Pathway And Therapeutic Effects Of Vamorolone." 2nd International Medicine And Pharmacy Congress , İstanbul, Turkey, pp.89-95, 2024
Helvacı, G. And Bilgin, A. (2024) . "New Horizons In Duchenne Muscle Dystrophy: Nuclear Factor Kappa Pathway And Therapeutic Effects Of Vamorolone." 2nd International Medicine And Pharmacy Congress , İstanbul, Turkey, pp.89-95.
@conferencepaper{conferencepaper, author={GÜLSÜM HELVACI And author={Aylin Bilgin}, title={New Horizons In Duchenne Muscle Dystrophy: Nuclear Factor Kappa Pathway And Therapeutic Effects Of Vamorolone}, congress name={2nd International Medicine And Pharmacy Congress}, city={İstanbul}, country={Turkey}, year={2024}, pages={89-95} }